Nutex Health PE ratio NUTX

Share price divided by earnings per share over the last twelve months, since 2016.

Today, Oct 23, 2026: 8.3×
10-year median: 11.0×
Against its 10-year history: 17th; percentile: 0 is its lowest day, 100 its highest
10-year range: 6.4× to 250×
Peer median: 11.1×

Nutex Health's PE ratio is 8.3× as of Oct 23, 2026: a share price of $209.59 against $25.40 of earnings per share over the last twelve months.

That is below its ten-year median of 11.0×, lower than on 83% of days in the last ten years.

Over that time it ranged from 6.4× in Aug 2026 to 250× in Apr 2017.

The median for 10 credit services stocks of a similar size is 11.1×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	8.3×	6.4×	15.0×
2025	n/m a value too high to mean anything
2024	n/m a value too high to mean anything
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	n/m a value too high to mean anything
2019	n/m a value too high to mean anything
2018	n/m a value too high to mean anything
2017	250×	50.0×	250×
2016	70.0×	67.8×	95.0×

Against its peers

Companies in Financial - Credit Services nearest Nutex Health's size, closest first, today.

Company	PE ratio
NUTXNutex Health	8.3×
LQDTLiquidity Services	44.0×
ATLCAtlanticus	11.3×
PGYPagaya Technologies	13.9×
HAPNHappen	8.5×
WDWalker & Dunlop	30.5×
JCAPJefferson Capital	8.3×
PWPPerella Weinberg Partners	59.0×
WUWestern Union CO	5.2×
ECPGEncore Capital	7.4×
AGMFederal Agricultural Mortgage	10.9×
Peer median	11.1×

Where Nutex Health ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Nutex Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.